Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dorr

Showing results (1011-1020 of 1,229) with videos related to

Pageof 123
Sort By:
Investigational New Drugs|June 6, 2009
A phase I trial of imexon, a pro-oxidant, in combination with docetaxel for the treatment of patients with advanced breast, non-small cell lung and prostate cancerStacy Moulder, Navneet Dhillon, Chaan Ng, et al.
Annals of Internal Medicine|October 2, 2001
Durable treatment-free remission after high-dose cyclophosphamide therapy for previously untreated severe aplastic anemiaR A Brodsky, L L Sensenbrenner, B D Smith, et al.
Investigational New Drugs|November 27, 2012
Characterization of a membrane-active anti-tumor agent, UA8967Robert T Dorr, Betty K Samulitis, Lee Wisner, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|December 8, 2025
Persistent dysmorphology and dysfunction of the brain microvasculature following repeated traumaAdrienne Dorr, Matthew Rozak, Andrew Stanisz, et al.
Applied Clinical Informatics|May 4, 2022
Generating and Reporting Electronic Clinical Quality Measures from Electronic Health Records: Strategies from EvidenceNOW CooperativesJoshua E Richardson, Luke V Rasmussen, David A Dorr, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 31, 2018
Thirty-Day Readmissions in Hospitalized Patients Who Received Bezlotoxumab With Antibacterial Drug Treatment for Clostridium difficile InfectionVimalanand S Prabhu, Oliver A Cornely, Yoav Golan, et al.
JAMA Network Open|March 13, 2026
Referrals to a Novel Health Care Equity Consult ServiceSamantha Guyah, Okeoma Mmeje, Prianka Shakil-Brown, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|August 3, 2023
American Indian Perspectives on Culturally Aligning a Digital Smoking Cessation ResourceChelsea Cooley, Wyatt Pickner, Rachel Widome, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2002
A randomized phase II and pharmacokinetic study of the antisense oligonucleotides ISIS 3521 and ISIS 5132 in patients with hormone-refractory prostate cancerAnthony W Tolcher, Leonard Reyno, Peter M Venner, et al.
Journal of Clinical and Translational Science|June 30, 2021
Clinical research during the COVID-19 pandemic: The role of virtual visits and digital approachesTammy L Loucks, Clare Tyson, David Dorr, et al.
Pageof 123

Showing results (1011-1020 of 1,229) with videos related to

Sort By:
Pageof 123
Investigational New Drugs|June 6, 2009
A phase I trial of imexon, a pro-oxidant, in combination with docetaxel for the treatment of patients with advanced breast, non-small cell lung and prostate cancerStacy Moulder, Navneet Dhillon, Chaan Ng, et al.
Annals of Internal Medicine|October 2, 2001
Durable treatment-free remission after high-dose cyclophosphamide therapy for previously untreated severe aplastic anemiaR A Brodsky, L L Sensenbrenner, B D Smith, et al.
Investigational New Drugs|November 27, 2012
Characterization of a membrane-active anti-tumor agent, UA8967Robert T Dorr, Betty K Samulitis, Lee Wisner, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|December 8, 2025
Persistent dysmorphology and dysfunction of the brain microvasculature following repeated traumaAdrienne Dorr, Matthew Rozak, Andrew Stanisz, et al.
Applied Clinical Informatics|May 4, 2022
Generating and Reporting Electronic Clinical Quality Measures from Electronic Health Records: Strategies from EvidenceNOW CooperativesJoshua E Richardson, Luke V Rasmussen, David A Dorr, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 31, 2018
Thirty-Day Readmissions in Hospitalized Patients Who Received Bezlotoxumab With Antibacterial Drug Treatment for Clostridium difficile InfectionVimalanand S Prabhu, Oliver A Cornely, Yoav Golan, et al.
JAMA Network Open|March 13, 2026
Referrals to a Novel Health Care Equity Consult ServiceSamantha Guyah, Okeoma Mmeje, Prianka Shakil-Brown, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|August 3, 2023
American Indian Perspectives on Culturally Aligning a Digital Smoking Cessation ResourceChelsea Cooley, Wyatt Pickner, Rachel Widome, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2002
A randomized phase II and pharmacokinetic study of the antisense oligonucleotides ISIS 3521 and ISIS 5132 in patients with hormone-refractory prostate cancerAnthony W Tolcher, Leonard Reyno, Peter M Venner, et al.
Journal of Clinical and Translational Science|June 30, 2021
Clinical research during the COVID-19 pandemic: The role of virtual visits and digital approachesTammy L Loucks, Clare Tyson, David Dorr, et al.
Pageof 123